ITOS
iTeos Therapeutics (ITOS)
$42
About iTeos Therapeutics (ITOS)
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.
Details
Daily high
$7.51
Daily low
$7.09
Price at open
$7.17
52 Week High
$18.75
52 Week Low
$7.09
Market cap
271.1M
Dividend yield
0.00%
Volume
2.4M
Avg. volume
548,118
P/E ratio
-2.36
iTeos Therapeutics News
Details
Daily high
$7.51
Daily low
$7.09
Price at open
$7.17
52 Week High
$18.75
52 Week Low
$7.09
Market cap
271.1M
Dividend yield
0.00%
Volume
2.4M
Avg. volume
548,118
P/E ratio
-2.36